【2026 Latest Edition】Survey Compares Mounjaro Prices Across 10 Major Online Medical Services, Revealing Up to 3.3x Difference in Initial Costs

'I want to start Mounjaro, but I don't know where to get a prescription.'

Responding to such concerns, WellnessPlus, Inc. (HQ: Shinagawa, Tokyo; CEO: Kazuma Yasui), which operates the online pharmacy 'Luxora,' conducted a price survey of 10 major online consultation services for Mounjaro 2.5mg (4 pens), a drug for type 2 diabetes.

The survey revealed that the estimated initial total cost ranges from 9,950 yen to 32,450 yen, indicating a price difference of up to approximately 3.3 times depending on the service. It was also confirmed that actual total payments fluctuate significantly due to incidental costs such as initial consultation fees, shipping, cold-chain delivery fees, and system usage fees, not just the base drug price.

In light of these findings, Luxora will launch a limited-time campaign from June 5 to June 7, 2026, to make weight management with Mounjaro more accessible.

Key Findings of the Survey

1. Initial Cost Variation of Up to 3.3x: The total estimated initial cost across the 10 services ranged from 9,950 yen to 32,450 yen, showing a large price gap based on the service selected.

2. More Than Just Drug Prices: The survey confirmed that actual costs vary greatly depending on additional fees such as initial consultation fees, delivery charges, cold-chain fees, and system usage fees, rather than just the displayed drug price.

3. Differences in Ongoing Costs: The importance of considering long-term costs became clear, as recurring expenses differ between services.

Luxora's Initiative

The survey highlighted how difficult it is for users to compare actual burdens due to differing fee structures and additional cost policies among clinics. Consequently, Luxora is running a limited-time campaign from June 5 to June 7, 2026.

- Campaign Price: 4,980 yen for the first month (tax included) - Bonus: 2,500 yen off by adding the official LINE account

Information on Private Medical Practice

- This treatment is a private medical practice (not covered by insurance). - Mounjaro is approved in Japan for type 2 diabetes; usage for medical weight loss is considered private practice. - Prescriptions may not be issued based on a doctor's medical judgment. - Service is unavailable to individuals under 18.